BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24810989)

  • 1. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
    Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P
    Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.
    Baia GS; Caballero OL; Orr BA; Lal A; Ho JS; Cowdrey C; Tihan T; Mawrin C; Riggins GJ
    Mol Cancer Res; 2012 Jul; 10(7):904-13. PubMed ID: 22618028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.
    Yokoyama T; Osada H; Murakami H; Tatematsu Y; Taniguchi T; Kondo Y; Yatabe Y; Hasegawa Y; Shimokata K; Horio Y; Hida T; Sekido Y
    Carcinogenesis; 2008 Nov; 29(11):2139-46. PubMed ID: 18725387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
    Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
    Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
    Wang Q; Ding J; Nan G; Lyu Y; Ni G
    J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of YAP1 defines neuroendocrine differentiation of lung tumors.
    Ito T; Matsubara D; Tanaka I; Makiya K; Tanei ZI; Kumagai Y; Shiu SJ; Nakaoka HJ; Ishikawa S; Isagawa T; Morikawa T; Shinozaki-Ushiku A; Goto Y; Nakano T; Tsuchiya T; Tsubochi H; Komura D; Aburatani H; Dobashi Y; Nakajima J; Endo S; Fukayama M; Sekido Y; Niki T; Murakami Y
    Cancer Sci; 2016 Oct; 107(10):1527-1538. PubMed ID: 27418196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
    Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.
    Jerhammar F; Johansson AC; Ceder R; Welander J; Jansson A; Grafström RC; Söderkvist P; Roberg K
    Oral Oncol; 2014 Sep; 50(9):832-9. PubMed ID: 24993889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.
    Hélias-Rodzewicz Z; Pérot G; Chibon F; Ferreira C; Lagarde P; Terrier P; Coindre JM; Aurias A
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1161-71. PubMed ID: 20842732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.
    Hong X; Nguyen HT; Chen Q; Zhang R; Hagman Z; Voorhoeve PM; Cohen SM
    EMBO J; 2014 Nov; 33(21):2447-57. PubMed ID: 25180228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.
    Li S; Yu Z; Chen SS; Li F; Lei CY; Chen XX; Bao JM; Luo Y; Lin GZ; Pang SY; Tan WL
    Urol Oncol; 2015 Oct; 33(10):427.e1-10. PubMed ID: 26163939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
    Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
    Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.
    Overholtzer M; Zhang J; Smolen GA; Muir B; Li W; Sgroi DC; Deng CX; Brugge JS; Haber DA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12405-10. PubMed ID: 16894141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.